¼¼°èÀÇ 3D ÇÁ¸°ÅÍ ÀÇÁö ½ÃÀåÀº 2024³â¿¡´Â 15¾ï 1,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾úÀ¸¸ç, 2034³â¿¡´Â 31¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç CAGR 7.5%·Î ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù.
Á¾Á¾ ¼Óµµ°¡ ´À¸®°í ºñ¿ëÀÌ ¸¹ÀÌ µé¸ç ¿©·¯ ¹øÀÇ ÇÇÆÃÀÌ ÇÊ¿äÇÑ ±âÁ¸ÀÇ Á¦Á¶ ¹æ¹ý°ú ´Þ¸®, 3D ÇÁ¸°ÆÃ ±â¼úÀº ´õ ºü¸£°í ºñ¿ë È¿À²ÀûÀÎ Á¢±Ù ¹æ½ÄÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¸ÂÃãÇü ¼Ö·ç¼ÇÀº »ý»ê ½Ã°£À» ´ÜÃàÇÏ¸é¼ Àü¹ÝÀûÀÎ »ç¿ëÀÚ °æÇèÀ» °³¼±ÇÕ´Ï´Ù. °³ÀÎÈ´Â ¼ºÀå¿¡ µû¶ó ¿ä±¸ »çÇ×ÀÌ ÀÚÁÖ ¹Ù²î°í ±³Ã¼°¡ ´õ ÀÚÁÖ ÇÊ¿äÇÑ ¼Ò¾Æ ȯÀÚ¿¡°Ô ƯÈ÷ À¯¿ëÇÕ´Ï´Ù. º¸Ã¶ ºÐ¾ßÀÇ Ã·´Ü 3D ÇÁ¸°ÆÃÀº °³º°ÈµÈ ÀÇ·á ±â±â¿¡ ´ëÇÑ Àü ¼¼°èÀÇ ÀÇ·á ¼ö¿ä¸¦ ÃæÁ·ÇÏ´Â µ¥ Å« µµ¾àÀÔ´Ï´Ù.
ÀûÃþ Á¦Á¶ ±â¼úÀÇ ¹ßÀü, ƯÈ÷ ½ºÅ×·¹¿À¸®¼Ò±×·¡ÇÇ(SLA), ¼±ÅÃÀû ·¹ÀÌÀú ¼Ò°á(SLS), À¶ÇÕ ÀûÃþ ¸ðµ¨¸µ(FDM)Àº ³»±¸¼ºÀÌ ¶Ù¾î³ª°í °¡º¿ì¸ç ±â´ÉÀûÀÎ ÀǼö ¹× ÀÇÁ· ºÎǰÀÇ Á¦ÀÛÀ» °¡´ÉÇÏ°Ô Çß½À´Ï´Ù. ¹Ì±¹ ½ÄǰÀǾ౹(FDA) µî ±ÔÁ¦ ±â°üÀÇ ½ÂÀÎÀ» ¹ÞÀº 3D ÇÁ¸°ÆÃ ÀǼö ¹× ÀÇÁ· ±â±âÀÇ Áõ°¡·Î ÀÌ ±â¼úÀº ½Å·Ú¼º°ú È®»ê ¼Óµµ¸¦ ³ôÀ̰í ÀÖ½À´Ï´Ù. ÀÇ·á¿ë Æú¸®¸Ó¿Í ÇÕ±Ý µî »ýüÀûÇÕ¼º Àç·áÀÇ °¡¿ë¼ºÀº ÀǼö ÀÇÁ· ÀåÄ¡ÀÇ ³»±¸¼º, Æí¾ÈÇÔ, ÀûÀÀ¼ºÀ» ´õ¿í Çâ»ó½ÃÄ×½À´Ï´Ù. ÀÌ·¯ÇÑ Çõ½ÅÀº »ý»ê Áֱ⸦ ´ÜÃàÇÒ »Ó¸¸ ¾Æ´Ï¶ó ÀǼö ÀÇÁ·ÀÇ Ç°Áú°ú Á¤¹Ðµµ¸¦ ³ô¿© ÀÇ·á Àü¹®°¡¿Í ȯÀÚ ¸ðµÎ¿¡°Ô ´õ Á¢±ÙÇϱ⠽¬¿î Á¦Ç°À» Á¦°øÇÕ´Ï´Ù.
½ÃÀå ¹üÀ§ | |
---|---|
½ÃÀå ¿¬µµ | 2024³â |
¿¹Ãø ¿¬µµ | 2025-2034³â |
½ÃÀÛ ±Ý¾× | 15¾ï 1,000¸¸ ´Þ·¯ |
¿¹Ãø ±Ý¾× | 31¾ï ´Þ·¯ |
CAGR | 7.5% |
Æú¸®ÇÁ·ÎÇÊ·»Àº À¯¸®ÇÑ °µµ ´ë Áß·® ºñÀ², ÇÇ·Î ÀúÇ×¼º ¹× ÈÇÐÀû ¾ÈÁ¤¼ºÀ¸·Î ÀÎÇØ 2024³â¿¡ 6¾ï 590¸¸ ´Þ·¯¸¦ âÃâÇϸç Àç·á ºÎ¹®À» ÁÖµµÇß½À´Ï´Ù. ÀÇ·á Á¦Á¶¿¡ ³Î¸® »ç¿ëµÇ´Â Æú¸®ÇÁ·ÎÇÊ·»Àº »ýü ÀûÇÕ¼º°ú »ì±Õ¿¡ ´ëÇÑ ³»¼ºÀ¸·Î ³ôÀº Æò°¡¸¦ ¹Þ°í ÀÖ½À´Ï´Ù. º¸Ã¶ ¼ÒÄÏ, ¼ö¼ú¿ë °¡ÀÌµå ¹× Á¤Çü¿ë ÁöÁö´ë Á¦ÀÛ¿¡ ±¤¹üÀ§ÇÏ°Ô »ç¿ëµË´Ï´Ù. 3D ÇÁ¸°ÆÃÀ» ÅëÇÑ °æ·®È ¹× °³ÀÎ ¸ÂÃãÇü ÀÇ·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó Æú¸®ÇÁ·ÎÇÊ·»ÀÇ È°¿ëµµ °è¼Ó È®´ëµÇ°í ÀÖ½À´Ï´Ù. ºÎµå·¯¿ò°ú ±â´É¼ºÀÌ Á¶È¸¦ ÀÌ·ç´Â Æú¸®ÇÁ·ÎÇÊ·»Àº ȯÀÚ Áß½ÉÀÇ µðÀÚÀο¡ ¼±È£µÇ´Â ¼ÒÀçÀÔ´Ï´Ù.
º¸Ã¶ Ŭ¸®´Ð ºÎ¹®Àº 2024³â¿¡ 46.1%ÀÇ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ÀÌ Àü¹® ¼¾Å͵éÀº ¸¸¼º Áúȯ(´ç´¢º´, Ç÷°ü Áúȯ µî)À¸·Î ÀÎÇÑ Àý´Ü ȯÀÚ°¡ ¸¹Àº Áö¿ª¿¡¼ Áõ°¡Çϴ ȯÀÚ ¼ö¸¦ °ü¸®Çϱâ À§ÇØ 3D ÇÁ¸°ÆÃÀ» Á¡Á¡ ´õ ÅëÇÕÇϰí ÀÖ½À´Ï´Ù. Ŭ¸®´ÐÀº 3D ÇÁ¸°ÆÃÀÇ È¿À²¼ºÀ¸·ÎºÎÅÍ ÇýÅÃÀ» ¹ÞÀ¸¸ç, ƯÈ÷ ¼Ò¾Æ ȯÀÚ¿¡°Ô Áß¿äÇÑ ºü¸¥ ¼öÁ¤°ú ÀÚÁÖ ±³Ã¼°¡ °¡´ÉÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ½Ã¼³Àº ÀçȰ, ÈÆ·Ã, ÈÄ¼Ó °ü¸® ¼ºñ½º¸¦ Á¦°øÇÏ´Â ¿ø½ºÅé Á¦°øÀÚ·Î ±â´ÉÇϸç, 3D ÇÁ¸°ÆÃ Àΰø °üÀýÀÇ Ã¤ÅÃÀ» ÃËÁøÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Áß¾Ó ÁýÁᫎ Á¢±Ù ¹æ½ÄÀº »ç¿ëÀÚ °æÇèÀ» ´Ü¼øÈÇϰí Àå±âÀûÀÎ ÇØ°áÃ¥À» ã´Â ȯÀÚµé »çÀÌ¿¡¼ ½Å·Ú¸¦ ½×¾Æ°©´Ï´Ù.
¹Ì±¹ÀÇ 3D ÇÁ¸°ÅÍ ÀÇÁö ½ÃÀåÀº ºñ¸¸, ´ç´¢º´, ¸»ÃÊ µ¿¸Æ ÁúȯÀÇ ¹ßº´·ü Áõ°¡¿¡ ÈûÀÔ¾î 2034³â±îÁö 12¾ï ´Þ·¯ ±Ô¸ð·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, À̴ ÷´Ü º¸Ã¶ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ±ä±ÞÇÑ Çʿ伺À» °Á¶Çϰí ÀÖ½À´Ï´Ù. ¿ø°Ý ÀÇ·á, Ŭ¶ó¿ìµå ±â¹Ý ¿öÅ©Ç÷οì, ¿ø°Ý ȯÀÚ ½ºÄ³´×°ú °°Àº µðÁöÅÐ °Ç° Çõ½ÅÀÇ ÅëÇÕÀº 3D ÇÁ¸°ÆÃ º¸Ã¶¹°ÀÇ È®ÀåÀ» À§ÇÑ À¯¸®ÇÑ Åä´ë¸¦ ¸¶·ÃÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀ¸·Î ÀÇ·áÁøÀº º¸´Ù Á¤È®ÇÏ°í ½Ã±âÀûÀýÇÑ Ä¡·á¸¦ Á¦°øÇÒ ¼ö ÀÖ°Ô µÇ¾î ÀÇ·á ºÐ¾ßÀÇ ¹Ì·¡¿¡ ´õ ³Î¸® äÅÃµÉ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù.
3D ÇÁ¸°ÅÍ ÀÇÁö ¾÷°è¸¦ Çü¼ºÇÏ´Â ÁÖ¿ä ±â¾÷À¸·Î´Â YouBionic, WillowWood, Mercuris, Limbitless Solutions, Stratasys, Bionic Prosthetics and Orthotics, Create Prosthetics, UNYQ, Protostics, Prothea, Open Bionics, Eqwal Group(Steeper Group) ½ÃÀåÀÇ ¹ßÆÇÀ» ±»È÷±â À§ÇØ 3D ÇÁ¸°ÅÍ ÀÇÁö ºÐ¾ßÀÇ ±â¾÷Àº ¿©·¯ Àü·«Àû Á¢±Ù ¹æ½ÄÀ» ½ÃÇàÇϰí ÀÖ½À´Ï´Ù. ÁÖ¿ä ÃÊÁ¡Àº °í±Þ ¼ÒÇÁÆ®¿þ¾î ¹× ½ºÄµ ±â¼úÀ» Ȱ¿ëÇÏ¿© Á¦Ç° »ç¿ëÀÚ Á¤ÀǸ¦ È®´ëÇÏ´Â °ÍÀÔ´Ï´Ù. ±â¾÷µéÀº Àç·á ǰÁú°ú Æí¾ÈÇÔÀ» °³¼±Çϱâ À§ÇØ ¿¬±¸°³¹ß(R&D)¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. º´¿ø, ÀçȰ ¼¾ÅÍ, ¿¬±¸ ±â°ü°úÀÇ Àü·«Àû Çù·ÂÀ» ÅëÇØ Á¢±Ù¼ºÀ» ³ôÀ̰í Çõ½ÅÀ» °¡¼ÓÈÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¿ø°Ý »çÁö ½ºÄ³´×°ú Ŭ¶ó¿ìµå ±â¹Ý µðÀÚÀÎ µî µðÁöÅÐ ¿öÅ©Ç÷ο츦 °ÈÇØ »ý»ê È¿À²¼ºÀ» ³ôÀÌ°í ¿Â¶óÀÎ Ç÷§Æû°ú Áö¿ªº° ÇÁ¸°ÆÃ Çãºê¸¦ ÅëÇØ Áö¸®Àû È®ÀåÀ» ÃßÁøÇϰí ÀÖ½À´Ï´Ù.
The Global 3D Printed Prosthetics Market was valued at USD 1.51 billion in 2024 and is estimated to grow at a CAGR of 7.5% to reach USD 3.1 billion by 2034, driven by the increasing demand for highly personalized prosthetic solutions, as patients seek devices tailored to their specific anatomy and day-to-day needs. Unlike conventional manufacturing methods-which are often slow and expensive and involve numerous fitting sessions-3D printing technology offers a faster and more cost-efficient approach. These custom solutions improve the overall user experience while cutting down production time. Personalization is especially valuable for pediatric patients, whose needs change frequently as they grow, requiring replacements more often. Advanced 3D printing in prosthetics is a major leap forward in meeting global healthcare demands for individualized medical devices.
Technological advancements in additive manufacturing, including Stereolithography (SLA), Selective Laser Sintering (SLS), and Fused Deposition Modeling (FDM), are enabling the creation of durable, lightweight, and functional prosthetic components. With the approval of multiple 3D printed prosthetic devices by regulatory bodies like the U.S. FDA, the technology continues gaining credibility and momentum. The availability of biocompatible materials such as medical-grade polymers and alloys has further enhanced the durability, comfort, and adaptability of prosthetic devices. These innovations not only reduce production cycles but also elevate the quality and precision of prosthetics, making them more accessible for medical professionals and patients alike.
Market Scope | |
---|---|
Start Year | 2024 |
Forecast Year | 2025-2034 |
Start Value | $1.51 Billion |
Forecast Value | $3.1 Billion |
CAGR | 7.5% |
Polypropylene led the material segment generating USD 605.9 million in 2024, owing to its favorable strength-to-weight ratio, fatigue resistance, and chemical stability. Widely adopted in medical manufacturing, polypropylene is valued for its biocompatibility and ability to withstand sterilization. It is extensively used to fabricate prosthetic sockets, surgical guides, and orthotic supports. As demand rises for lightweight and personalized medical solutions via 3D printing, the utilization of polypropylene continues to expand. Its blend of softness and functionality makes it a preferred choice in patient-centric designs.
The prosthetic clinics segment held a 46.1% share in 2024. These specialized centers are increasingly integrating 3D printing to manage growing patient volumes, especially in regions with high rates of amputation caused by chronic conditions like diabetes and vascular disease. Clinics benefit from 3D printing's efficiency, as it allows for quick modifications and frequent replacements-particularly vital for pediatric patients. These facilities often serve as all-in-one providers, offering rehabilitation, training, and follow-up services, encouraging greater adoption of 3D printed prosthetics. Their centralized approach simplifies the user experience and builds trust among patients seeking long-term solutions.
U.S. 3D Printed Prosthetics Market is expected to reach USD 1.2 billion by 2034 driven by rising incidences of obesity, diabetes, and peripheral artery disease, underscoring the urgent need for advanced prosthetic solutions. The integration of digital health innovations such as telehealth, cloud-based workflows, and remote patient scanning is creating fertile ground for the expansion of 3D printed prosthetics. These developments allow clinicians to deliver more accurate and timely care, contributing to broader adoption across the healthcare landscape.
Key players shaping the 3D Printed Prosthetics Industry include YouBionic, WillowWood, Mercuris, Limbitless Solutions, Stratasys, Bionic Prosthetics and Orthotics, Create Prosthetics, UNYQ, Protosthetics, Prothea, Open Bionics, Eqwal Group (Steeper Group), Materialise, Exone, and Motorica. To strengthen their market foothold, companies in the 3D printed prosthetics space are implementing multiple strategic approaches. A primary focus is expanding product customization by leveraging advanced software and scanning technologies. Firms are also investing in R&D to improve material quality and comfort. Strategic collaborations with hospitals, rehabilitation centers, and research institutions are helping to increase access and accelerate innovation. In addition, companies are enhancing digital workflows, such as remote limb scanning and cloud-based design, to streamline production and expand geographically through online platforms and localized printing hubs.